Algiessac (Sodium Alginate)

Adult dose

1. For hemostasis and improvement of subjective symptoms in gastric and duodenal ulcers and erosive gastritis, and improvement of subjective symptoms in gastroesophageal reflux disease: Sodium alginate is generally administered orally at a dose of 1–3g (equivalent to about 20–60mL) 3–4 times a day on an empty stomach. If oral administration is not possible, it can be administered via nasal tube (sonde). 2. For hemostasis in gastric biopsy bleeding: Generally, a dose of 0.5–1.5g (equivalent to about 10–30mL) is administered endoscopically and 1.5g (equivalent to about 30mL) is administered orally.

This medicine may occasionally cause gastrointestinal symptoms such as diarrhea or constipation during administration. If such symptoms occur, you should immediately stop taking the medication and consult a doctor or dentist. It is advisable to bring the attached documents related to this medication during the consultation. Furthermore, caution is needed as this medicine may not convert to gel form properly in states of low gastric acid, reducing its effectiveness. Lastly, this medication contains caramel; patients with a history of allergies or hypersensitivity to this ingredient should consider it carefully and consult a physician before use.

Mild side effects

Diarrhea, constipation

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication for a long time.

Appearance

A viscous liquid that is light brown, contained in aluminum foil pouches.

Package unit

20mL/pack X 40EA, 25mL/pack X 40EA, 25mL/pack X 20EA